IRIDEX (NASDAQ:IRIX) Announces Earnings Results

IRIDEX (NASDAQ:IRIX) posted its earnings results on Tuesday. The medical equipment provider reported ($0.12) earnings per share (EPS) for the quarter, Zacks reports. The firm had revenue of $11.58 million during the quarter. IRIDEX had a negative return on equity of 163.45% and a negative net margin of 22.79%. During the same period last year, the firm posted ($0.11) EPS.

IRIDEX Trading Down 4.7 %

IRIX stock opened at $1.80 on Thursday. IRIDEX has a 1-year low of $1.27 and a 1-year high of $3.65. The stock has a market cap of $29.75 million, a P/E ratio of -2.82 and a beta of 0.80. The stock’s fifty day simple moving average is $1.68 and its two-hundred day simple moving average is $2.03.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on shares of IRIDEX in a report on Saturday, November 9th. They set a “hold” rating on the stock.

IRIDEX Company Profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.